Back to VANGUARD GROUP INC VANGUARD GROUP INC

NRXPNRXP
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in NRX PHARMACEUTICALS INC

As of its last 13F, for Q4 2025, Vanguard Group held 729,842 shares of NRXP (NRX Pharmaceuticals), worth $2M. It increased the position by 194,886 shares (+36.4%) from Q3 2025. Vanguard Group held NRXP from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$2M

Current Shares

729,842

Total Value Change

+$1.6M

Total Shares Change

+489,526

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
729,842
+36.4%
$2M0.0%$2.63
23
2025-Q3
Increased
534,956
+18.3%
$1.8M0.0%$3.25
21
2025-Q2
Increased
452,175
+16.3%
$1.5M0.0%$3.42
20
2025-Q1
Increased
388,925
+61.8%
$797,2960.0%$2.03
24
2024-Q4
Unchanged
240,316
0.0%
$528,6950.0%$1.53
0
2024-Q3
First report
240,316
-
$406,1340.0%$1.75
0

Other major holders of NRXP: VANGUARD CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, BALYASNY ASSET MANAGEMENT L.P., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used